Dasatinib plus Quercetin

Dasatinib + Quercetin (D+Q) is a well-studied senolytic compound combination designed to selectively eliminate senescent cells. By targeting key pathways that allow damaged cells to persist, D+Q promotes tissue rejuvenation and supports anti-aging research models. 

• Dasatinib: A tyrosine kinase inhibitor that interferes with pro-survival pathways in senescent cells.
   
• Quercetin: A natural flavonoid that enhances senescent cell clearance by inhibiting anti-apoptotic proteins.
   
• Together, D+Q selectively induces apoptosis in senescent cells while sparing healthy cells.

• Oral administration potential for experimental models.
   
• Broad literature support with multiple preclinical and early clinical studies.
   
• Cost-effective small molecule combination, suitable for routine laboratory use.

• Efficacy may vary across different cell types.
   
• Potential side effects require careful monitoring in experimental settings.
   
• Primarily used in research; not approved for clinical therapy.

• Anti-aging studies and senescence biology.
   
• Age-related disease models.
   
• Preclinical evaluation of senolytic interventions.

D+Q offers a reliable, reproducible approach to clear senescent cells in vitro and in vivo. Its documented activity makes it a preferred tool for laboratories exploring cellular aging, tissue regeneration, and age-associated pathologies. 

For research and laboratory use, D+Q is available in bulk quantities with consistent quality. Learn more and place orders at https://retatrutidesupplier.com/dasatinib-plus-quercetin